Package Contents: 1 box, 1 vial of BPC-157, 5 mg/vial
GLP-1 drugs produce dramatic, rapid weight loss by maintaining supraphysiological levels of synthetic GLP-1 in the bloodstream around the clock
The findings underscore the importance of setting clear expectations with patients early in treatment, including the possibility that more than one medication may be prescribed before a long-term approach is identified
Also, during STEP 5, a study to assess efficacy of semaglutide with a follow-up of 2 years, there is a post-hoc analysis that demonstrates a better performance in the self-reported Control of Eating Questionnaire(CoEQ) to measure changes in appetite versus placebo, with lower cravings for dairy and starchy foods and less desire for salty and spicy food at short-term (20 weeks) but also as a maintenance therapy at weeks 52 and 104 (178)
its a controlled substance
The advertised price may only apply to very low doses, while higher doses cost significantly more